Arrowhead Pharmaceuticals
ARWR
#4521
Rank
S$2.25 B
Marketcap
$16.40
Share price
-4.20%
Change (1 day)
-57.07%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): -$2.37

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.28. In 2022 the company made an earnings per share (EPS) of -$1.96 an increase over its 2021 EPS that were of -$2.36.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.3720.99%
2022-$1.96-17.05%
2021-$2.3674.26%
2020-$1.36-283.64%
2019$0.74-257.14%
2018-$0.47-27.08%
2017-$0.64-59.32%
2016-$1.59-21.85%
2015-$2.039.42%
2014-$1.852.87%
2013-$1.80-31.56%
2012-$2.63300%
2011-$0.66-45.56%
2010-$1.21-66.67%
2009-$3.63-63.51%
2008-$9.94-12.94%
2007-$11.4244.07%
2006-$7.9377.35%
2005-$4.4710.66%
2004-$4.04-54.25%
2003-$8.83-80.51%
2002-$45.303.87%
2001-$43.61116.17%
2000-$20.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.52 141.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.11-192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.87-61.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.92-928.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.28 437.65%๐Ÿ‡บ๐Ÿ‡ธ USA